• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . . Integrated histopathology, spatial and single cell transcriptomics resolve cellular drivers of early and late alveolar damage in COVI

tetano

Editor, Senior Moderator
Nat Commun


. 2025 Mar 10;16(1):1979.
doi: 10.1038/s41467-025-56473-x. Integrated histopathology, spatial and single cell transcriptomics resolve cellular drivers of early and late alveolar damage in COVID-19

Jimmy Tsz Hang Lee[SUP] #[/SUP][SUP] 1 [/SUP], Sam N Barnett[SUP] #[/SUP][SUP] 2 3 [/SUP], Kenny Roberts[SUP] 1 [/SUP], Helen Ashwin[SUP] 4 [/SUP], Luke Milross[SUP] 5 [/SUP], Jae-Won Cho[SUP] 6 [/SUP], Alik Huseynov[SUP] 2 [/SUP], Benjamin Woodhams[SUP] 1 7 [/SUP], Alexander Aivazidis[SUP] 1 [/SUP], Tong Li[SUP] 1 [/SUP], Joaquim Majo[SUP] 8 [/SUP], Patricia Chaves[SUP] 2 [/SUP], Michael Lee[SUP] 2 [/SUP], Antonio M A Miranda[SUP] 2 [/SUP], Zuzanna Jablonska[SUP] 2 [/SUP], Vincenzo Arena[SUP] 9 [/SUP], Brian Hanley[SUP] 10 [/SUP], Michael Osborn[SUP] 10 [/SUP], Virginie Uhlmann[SUP] 7 [/SUP], Xiao-Ning Xu[SUP] 11 [/SUP], Gary R McLean[SUP] 2 12 [/SUP], Sarah A Teichmann[SUP] 1 13 [/SUP], Anna M Randi[SUP] 2 3 [/SUP], Andrew Filby[SUP] 14 [/SUP], Paul M Kaye[SUP] 4 [/SUP], Andrew J Fisher[SUP] 15 16 [/SUP], Martin Hemberg[SUP] 17 [/SUP], Michela Noseda[SUP] 18 19 [/SUP], Omer Ali Bayraktar[SUP] 20 [/SUP]



Affiliations
Free PMC article Abstract

The most common cause of death due to COVID-19 remains respiratory failure. Yet, our understanding of the precise cellular and molecular changes underlying lung alveolar damage is limited. Here, we integrate single cell transcriptomic data of COVID-19 and donor lung tissue with spatial transcriptomic data stratifying histopathological stages of diffuse alveolar damage. We identify changes in cellular composition across progressive damage, including waves of molecularly distinct macrophages and depletion of epithelial and endothelial populations. Predicted markers of pathological states identify immunoregulatory signatures, including IFN-alpha and metallothionein signatures in early damage, and fibrosis-related collagens in late damage. Furthermore, we predict a fibrinolytic shutdown via endothelial upregulation of SERPINE1/PAI-1. Cell-cell interaction analysis revealed macrophage-derived SPP1/osteopontin signalling as a key regulator during early steps of alveolar damage. These results provide a comprehensive, spatially resolved atlas of alveolar damage progression in COVID-19, highlighting the cellular mechanisms underlying pro-inflammatory and pro-fibrotic pathways in severe disease.


 
Back
Top Bottom